日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Ribociclib in Sequential Combination with Doxorubicin in Anthracycline-Naïve Advanced Soft-Tissue Sarcomas: Results of a Dose-Finding Phase Ib Study

瑞博西尼联合多柔比星序贯治疗蒽环类药物初治的晚期软组织肉瘤：一项剂量探索性 Ib 期研究的结果

期刊:Clinical Cancer Research
影响因子:10.2
doi:10.1158/1078-0432.CCR-24-4001
Davis, Lara E; Zhu, Limin; Latour, Emile; McMahon, Nathan; Nishikawa, Go; Choo, Florence; Nusser, Kevin D; Pittsenbarger, Janét; Burch, Reid; Park, Byung; Mills, Gordon B; Davis, Jessica L; Davare, Monika; Ryan, Christopher W
发表日期：2025
文献求助 收藏

Author Correction: TKI type switching overcomes ROS1 L2086F in ROS1 fusion-positive cancers

作者更正：TKI类型转换可克服ROS1融合阳性癌症中的ROS1 L2086F突变

期刊:npj Precision Oncology
影响因子:8
doi:10.1038/s41698-024-00676-w
Thawani, Rajat; Repetto, Matteo; Keddy, Clare; Nicholson, Katelyn; Jones, Kristen; Nusser, Kevin; Beach, Catherine Z; Harada, Guilherme; Drilon, Alexander; Davare, Monika A
肿瘤
肿瘤免疫
发表日期：2024
文献求助 收藏

TKI type switching overcomes ROS1 L2086F in ROS1 fusion-positive cancers.

TKI 类型转换可克服 ROS1 融合阳性癌症中的 ROS1 L2086F 突变

期刊:npj Precision Oncology
影响因子:8
doi:10.1038/s41698-024-00663-1
Thawani Rajat, Repetto Matteo, Keddy Clare, Nicholson Katelyn, Jones Kristen, Nusser Kevin, Beach Catherine Z, Harada Guilherme, Drilon Alexander, Davare Monika A
肿瘤
肿瘤免疫
发表日期：2024
文献求助 收藏

Corrigendum: Functional impact and targetability of PI3KCA, GNAS, and PTEN mutations in a spindle cell rhabdomyosarcoma with MYOD1 L122R mutation

更正：PI3KCA、GNAS 和 PTEN 突变在伴有 MYOD1 L122R 突变的梭形细胞横纹肌肉瘤中的功能影响和靶向性

期刊:Cold Spring Harbor Molecular Case Studies
影响因子:1.8
doi:10.1101/mcs.a006216
Choo, Florence; Odintsov, Igor; Nusser, Kevin; Nicholson, Katelyn; Davis, Lara; Corless, Christopher L; Stork, Linda; Somwar, Romel; Ladanyi, Marc; Davis, Jessica L; Davare, Monika A
MYOD1
细胞生物学
横纹肌肉瘤
PTEN
发表日期：2022
文献求助 收藏